Hemant Kalia, MD
Interventional Pain Medicine · Rochester, NYNPI 1689879959
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Abbott at 58.8% of the total. 2025 is the largest year on record at $58,718, more than ten times the $1,952 reported in 2019. Among interventional pain medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 486 payments — averaging $368.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$105K
- Averitas Pharma Inc.$25K
- Curonix LLC$12K
- Saluda Medical Americas, Inc.$11K
- Bioventus LLC$8K
- Nalu Medical, Inc.$3K
- plus $14K from 19 others
Across 47 payments — averaging $1193.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$55K
- Medtronic$820
What the payments were for
- Consulting fees$34,80019%
- Speaking & faculty fees$95,39153%
- Travel & lodging$32,87918%
- Food & beverage$16,1389%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 277 | $105,352 |
| Averitas Pharma Inc. | 34 | $25,362 |
| Curonix LLC | 22 | $11,806 |
| Saluda Medical Americas, Inc. | 13 | $11,102 |
| Bioventus LLC | 11 | $8,189 |
| Nalu Medical, Inc. | 12 | $3,440 |
| Tersera Therapeutics LLC | 10 | $2,945 |
| Si-bone, Inc. | 5 | $2,092 |
| GRT US Holding, Inc. | 1 | $2,000 |
| SPR Therapeutics, Inc | 16 | $1,349 |
| Vertos Medical, Inc. | 8 | $1,094 |
| Boston Scientific | 15 | $993 |
| Medtronic(2 entities) | 16 | $934 |
| Nevro Corp. | 25 | $815 |
| Merit Medical Systems Inc | 3 | $730 |
| Stratus Medical, LLC | 5 | $300 |
| Globus Medical | 3 | $184 |
| Spinal Simplicity, LLC | 1 | $154 |
| Lenoss Medical Inc | 1 | $112 |
| AstraZeneca | 2 | $97 |
| Foundation Fusion Solutions, LLC | 2 | $67 |
| Relievant Medsystems, Inc. | 1 | $29 |
| Eisai Inc. | 1 | $24 |
| Vertex | 1 | $23 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$84,681
- Qutenza$26,918
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$11,791
- Evoke$10,722
- Stimrouter Implantable Kit$7,847
- Proclaim DRG IPG$3,750
- Nalu Neurostimulation System$3,189
- PRIALT$2,801
- Proclaim IPG$2,622
- IFUSE IMPLANT SYSTEM$1,957
- Axium INS DRG IPG$1,500
- Axium$1,356
- mild Device Kit$872
- SPRINT PNS System$792
- PRODIGY$761
- IonicRF Generator$563
- ETERNA$540
- Proclaim Family of SCS IPGs$446
- INFINITY$434
- Senza$415
How this compares
$179,207 in reported general payments places this provider in the 95th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 152 | $5,435 |
| Buprenorphine | 12 | $4,495 |
| Gabapentin | 109 | $1,211 |
| Pregabalin | 87 | $996 |
| Duloxetine Hcl | 60 | $836 |
| Etodolac ErEtodolac | 15 | $772 |
| Baclofen | 52 | $709 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 68 | $693 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $681 |
| Morphine Sulfate | 25 | $679 |
| Morphine Sulfate ErMorphine Sulfate | 15 | $598 |
| Hydromorphone Hcl | 26 | $353 |
| Tizanidine Hcl | 80 | $349 |
| Nabumetone | 33 | $331 |
| Tramadol Hcl | 18 | $225 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Rochester
- Sharmeen HussainiRochester$10K
- Corey HunterNew York$446K
- Neel MehtaNew York$432K
- Martin FerrilloAlbany$164K
- George ChaseKew Gardens$102K
- Kimberly SackheimNew York$102K
- Suelane OuroNew York$68K
- Gerard DegregorisNew York$49K
- Jafar SiddiquiWilliamsville$45K
- Alexander WeingartenSyosset$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.